Recently, Weigao Orthopaedics announced the official appointment of Mr. Li Jinqu as the company’s new General Manager, succeeding the previous management team. This leadership change represents a strategic decision made amid the company’s ongoing efforts to deepen its strategic transformation, enhance operational efficiency, and accelerate its global expansion. Mr. Li brings over two decades of extensive experience in the medical device industry, having held senior executive roles at several prominent domestic and international healthcare companies. He is recognized for his strong strategic planning capabilities and market development expertise. In his new role, Mr. Li will oversee the company’s day-to-day operations and drive key initiatives including product innovation, channel optimization, and global market expansion. As a leading Chinese manufacturer of orthopedic medical devices, Weigao Orthopaedics has consistently increased its R&D investment in recent years to deliver high-quality, cost-effective orthopedic solutions. The Board of Directors expressed confidence that Mr. Li’s leadership will further strengthen corporate governance, boost overall competitiveness, and create greater value for shareholders and customers alike. The appointment is effective immediately, marking a new phase of high-quality growth for Weigao Orthopaedics.
近日，威高骨科（Weigao Orthopaedics）宣布正式聘任李进取先生为公司新任总经理，接替前任管理层职务。此次人事任命是公司在深化战略转型、提升运营效率和加速国际化布局背景下的重要决策。李进取在医疗器械行业拥有逾二十年的丰富经验，曾先后在多家国内外知名医疗企业担任高管职务，具备卓越的战略规划能力与市场开拓经验。加入威高骨科后，他将全面负责公司日常经营管理，并推动产品创新、渠道优化及全球市场拓展等核心工作。威高骨科作为中国领先的骨科医疗器械制造商，近年来持续加大研发投入，致力于提供高质量、高性价比的骨科解决方案。董事会表示，相信李进取的加入将进一步强化公司治理结构，提升综合竞争力，并为股东和客户创造更大价值。此次任命自公告之日起生效，标志着威高骨科迈入高质量发展的新阶段。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/2417.html